End to End AI Platform
Leading the Biotech Industry With Preemptive Technology
We Advance the Next Wave of Therapeutic Discovery
The Growing Wellness Market
The health concerns raised by COVID-19 have highlighted numerous unmet medical and wellness needs, driving a significant demand for novel drug discovery. People are increasingly eager to enhance their quality of life and overall wellness. Current products on the market often offer generic, standardised dosages, but individual absorption and side effects can vary greatly based on factors such as age and weight.
At our company, we recognise these critical variations and aim to address them by leveraging our state-of-the-art tools to develop innovative therapeutic solutions that meet these diverse needs.
Our Technology
We harness the power of machine learning and predictive analytics to accelerate the therapy development process and validate treatment effectiveness using advanced techniques like Generative Recurrent Neural Networks, GANs, and Bayesian Networks.
We aim to deliver clear, impactful solutions that enhance user experience, addressing a long-standing objective of the biotech and life sciences industries. Our end-to-end platform leverages emerging AI technology to streamline reagent selection, biomedical, and clinical research, facilitating more effective and accurate therapeutic discoveries.
Our Vision
As a pioneer in the life sciences industry, our mission is to accelerate the discovery of innovative solutions that address unmet medical needs and enhance overall well-being through our advanced AI technology. By uniting biologists, bioinformaticians, data scientists, and software engineers, we create synergistic value for all stakeholders. We share our life-changing end-to-end platform empowered by state-of-the-art AI technology with like-minded collaborators.
Our Goal
Our goal is to identify pressing global health challenges and deliver innovative solutions that enhance quality of life for all. We believe that by addressing these issues, we can transform the world and promote the well-being of humanity.
Our ever-evolving AI Platform, PetaPoly™ 4.0, represents a significant milestone in the life sciences field. It serves as a powerful tool to accelerate and validate new therapy discovery and repurposing, driving innovation and improving patient outcomes.
How Does It Works?
FAST
Efficient
Our AI-augmented model empowered our bio-chemist team to evaluate millions of molecular structures, curate effective therapy in fewer cycles.
This not only significantly reduces costs associated with unnecessary trials but also allows our team to focus on advancing scientific research for transformative wellness solutions. As a result, we are emerging as a pioneer in the biotech industry, dedicated to effective solution discovery.
SAFE
Secure
The utilization of our unprecedented AI platform would minimize the risk involved by conducting numerous of simulations for testing of toxicity and efficacy to validate the new therapeutic discovery, to make the most precise and effective solutions.
Wellness Products
Tackling Cancers
Others
Development Course
OUR TEAM
Our Professions & Specialists
Our professional team including specialists in Artificial Intelligence Software Engineering, Biochemistry, Bioinformatics, Cheminformatics, Computational Biology, Medicinal Chemistry, Pharmaceutical Science, Pharmacy, Pharmacology,
Join Us
Talents in life science field and specialists in Artificial Intelligence software engineering are welcome to join us for a brilliant career path!
Enquiry
We will reply as soon as we can
Contact Us
Tel: +852 2170 1399
Fax: +852 2764 0032
Headquarter
Unit 1907-1908, 19/F, Enterprise Square 3, No.39 Wang Chiu Road, Kowloon Bay, Hong Kong
HKSTP Laboratory
Unit 506, 5/F, Biotech Centre 1 (9W), Phase 2, Hong Kong Science Park, 9 Science Park West Avenue, Pak Shek Kok, Tai Po, New Territories, Hong Kong
Shenzhen Laboratory
Unit 428, Building 1, Yinxing Technology Park Phase ll, Guanlan Community, Longhua District, Shenzhen
@2024 Life Code Limited